November 14, 2013
Smith & Nephew is providing this notice to advise users of its RENASYS EZ and RENASYS EZ Plus Negative Pressure Systems of a design modification to the bacterial overflow guard (filter) to reduce the potential of introducing air leakage in the vacuum circuit during system set-up and operation.
April 23, 2013
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the conclusion of the fourth Negative Pressure Wound Therapy (NPWT) Expert Panel and further progress in developing a comprehensive, evidence-based consensus on the use of NPWT.
January 8, 2013
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces two independent clinical evaluations that indicate favourable results in preventing surgical site infections (SSI) when using the PICO Negative Pressure Wound Therapy System (“PICO”) post operatively following a Caesarean section.
January 3, 2012
Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announces the FDA clearance of the pocket-sized PICO* system, a single use Negative Pressure Wound Therapy (NPWT) system. PICO* is cleared for use both in a hospital and homecare setting and expands the use of NPWT from the traditional wound care population to include a wider range of patients undergoing orthopaedic surgery, plastic surgery and general surgical procedures.
St. Petersburg FL. June 6, 2011
Smith & Nephew's Advanced Wound Management division (LSE: SN; NYSE: SNN) today announced the launch of ALLEVYN* Gentle Border Sacrum, a new dressing that incorporates Gentle Border technology and is designed specifically for managing wounds located in the sacral area.
Hull, England. May 25, 2011
The Advanced Wound Management division of Smith & Nephew, (LSE: SN; NYSE: SNN) today announced the CE Mark approval for PICO*, an effective, single-use, Negative Pressure Wound Therapy (NPWT) system for acute and chronic wounds, high-risk surgical incisions and skin grafts.
May 6, 2011
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces its results for the first quarter ended 2 April 2011.